Juvenile Myelomonocytic Leukemia-Reference-Cited by-同舟云学术

Juvenile Myelomonocytic Leukemia

Published:1997-07-15 Issue:2 Volume:90 Page:479-488
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Aricò Maurizio¹,Biondi Andrea¹,Pui Ching-Hon¹

Affiliation:

1. From the Department of Pediatrics, University of Pavia, IRCCS Policlinico S. Matteo, Pavia, Italy; Department of Pediatrics, University of Milano, Ospedale S. Gerardo, Monza, Italy; Departments of Hematology-Oncology and Pathology and Laboratory Medicine, St Jude Children's Research Hospital, Memphis, TN; and the University of Tennessee, Memphis, College of Medicine, Memphis, TN.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/90/2/479/235745/479.pdf

Reference103 articles.

1. Chronic myelosis in children.;Eisenberg;J Lab Clin Med,1934

2. Chronic myelogenous leukemia in children.;Cooke;J Pediatr,1953

3. La leucemie myeloide chronique de l'enfant.;Bernard;Arch Fr Pediatr,1962

4. Chronic granulocytic leukemia of childhood. Clinical and cytogenetic studies.;Reisman;J Pediatr,1963

5. Hemoglobin and red cell enzymes changes in juvenile myeloid leukemia.;Weatherall;BMJ,1968

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline Neurofibromin 1 mutation enhances the anti‐tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity;British Journal of Haematology;2023-05-05

2. Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia;Scientific Reports;2022-08-30

3. Chronic myeloid leukemia: a type of MPN;Blood Research;2022-05-30

4. Immunophenotypic changes in juvenile myelomonocytic leukaemia after treatment with hypomethylating agent: Do they help to evaluate dept of response?;British Journal of Haematology;2022-02-21

5. Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment;Blood Advances;2021-11-23